Keywords: Endometrial carcinoma; Genetics; Microsatellite instability; PTEN; PIK3CA; K-RAS; Beta-catenin; Apoptosis; Chromosomal instability; E-cadherin; TP53;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Proteome profiling; Non-small cell lung cancer; SILAC; PCA; K-Ras; EGFR
Keywords: AMPK; AMP-activated protein kinase; ACC; acetyl-CoAcarboxylase; COX; cyclooxygenase; CDK; cyclin-dependent kinase; CaMK; Ca2+/calmodulin-dependent protein kinase; CPT; Cholinephosphotransferase; Egr; early growth response gene; ERK; extracellular signal-r
Keywords: Bicyclic peptide; Combinatorial library; Inhibition; K-Ras; Protein-protein interaction;
Keywords: Oncogene-induced inflammation; p53; K-RAS; WNT; NF-kappaB; STAT3;
Keywords: Epidermal growth factor receptor; Estrogen receptor; K-Ras; Non-small-cell-lung-cancer; Tobacco;
Keywords: PRDX; peroxiredoxin; Tg; transgenic; iPLA2; calcium-independent phospholipase 2; AP-1; activating protein-1; MAPK; mitogen-activated protein kinase; JNK; c-Jun NH2-terminal kinase; SAPK2, p38; stress-activated protein kinase 2; ERK1/2; p44/p42, extracellu
Keywords: EGFR, epidermal growth factor receptor; KRAS, Kirsten rat sarcoma viral oncogene homolog; ALK, Anaplastic Lymphoma Kinase; FISH, fluorescent in situ hybridization; IHC, immunohistochemistry; NSCLC, non-small-cell lung cancerLung; Adenocarcinoma; K-RAS; Cr
Analysis of Kras gene from induced pancreatic cancer rats administered with Momordicacharantia and Ocimumbasilicum leaf extracts
Keywords: K-Ras; Momordica charantia; Ocimum basilicum; Pancreatic cancer; Rats;
Arginine inhibits the malignant transformation induced by interferon-gamma through the NF-κB-GCN2/eIF2α signaling pathway in mammary epithelial cells in vitro and in vivo
Keywords: IFN-γ; Interferon gamma; Arg; Arginine; NF-κB; nuclear factor kappa-light-chain-enhancer of activated B cells; GCN2; general control nonderepressible 2; eIF2α; eukaryotic initiation factor 2; BMECs; bovine mammary epithelial cells; BC; breast cancer; R
Calmodulin and IQGAP1 activation of PI3Kα and Akt in KRAS, HRAS and NRAS-driven cancers
Keywords: KRAS4B; Ras isoforms; K-Ras; H-Ras; N-Ras; Plasma membrane; Calcium; Proliferation; Phosphorylated tyrosine motif; Drug discovery;
Concomitance of EGFR mutations and ALK rearrangement in patients with Lung Cancer
Keywords: ALK; Anaplastic lymphoma kinase; EGFR; Epithelial growth factor receptor; EML4; Echinoderm Microtubule Associated Protein Like 4; K-Ras; Kirsten rat sarcoma viral; MAPK; Mitogen-activated protein kinases; NSCLCs; Non-small cell lung cancers; PI3K; Phospha
Pulmonary adenocarcinoma with enteric differentiation: Dissecting oncogenic genes alterations with DNA sequencing and FISH analysis
Keywords: Lung adenocarcinoma; Enteric; EGFR; K-RAS; ALK; PIK3CA;
K-Ras(G12D)-selective inhibitory peptides generated by random peptide T7 phage display technology
Keywords: K-Ras; G12D-mutation; Inhibitor; Peptide; Phage display; K-Ras; V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; SOS; son of sevenless; PPI; Protein-protein interaction;
Short CommunicaitonTumor regression grades, K-RAS mutational profile and c-MET in colorectal liver metastases
Keywords: Colorectal cancer; Liver metastasis; K-RAS; C-MET;
Molecular interaction between K-Ras and H-REV107 in the Ras signaling pathway
Keywords: Signaling pathway; K-Ras; H-REV107; Mutation;
Anti-tumor effects of NVP-BKM120 alone or in combination with MEK162 in biliary tract cancer
Keywords: PI3K inhibitor; MEK inhibitor; K-Ras; Biliary tract cancer;
The cornerstone K-RAS mutation in pancreatic adenocarcinoma: From cell signaling network, target genes, biological processes to therapeutic targeting
Keywords: K-RAS; Pancreatic cancer; Cell signaling; Metabolism reprogramming; Therapy;
Enhanced B-Raf-mediated NRF2 gene transcription and HATs-mediated NRF2 protein acetylation contributes to ABCC1-mediated chemoresistance and glutathione-mediated survival in acquired topoisomerase II poison-resistant cancer cells
Keywords: ABC; ATP-binding cassette; ABCC; The ABC subfamily C; ABCC1; ATP-binding cassette subfamily C member 1; AHR; aryl hydrocarbon receptor; AKR1C1; aldo-keto reductase family 1 member C1; AREs; antioxidant-responsive elements; B-Raf; B-Raf proto-oncogene, ser
K-Ras and its inhibitors towards personalized cancer treatment: Pharmacological and structural perspectives
Keywords: Personalized medicine; Inhibitors; K-Ras; Cancer; SAR; Signaling pathways;
Intracranial response to nivolumab in NSCLC patients with untreated or progressing CNS metastases
Keywords: CNS; central nervous system; K-RAS; Kirsten rat sarcoma; mRECIST; modified Response Evaluation Criteria in Solid Tumors; MRI; magnetic resonance imaging; NSCLC; non-small cell lung cancer; pts; patients; PET-CT; positron emission tomography-computer tomog
Chromosome aberrations [dup(1q)] in endometrial cancer: Gene analysis of 54 surgical specimens in Turkey
Keywords: chromosomal abnormalities; endometrial cancer; Her-2/neu; k-ras
Immunohistochemical and genetic evaluations of epidermal growth factor receptor (EGFR) in oral squamous cell carcinoma
Keywords: Oral squamous cell carcinoma; EGFR gene alterations; EGFR protein expression; K-Ras; Ki-67
Oncogenic KRAS signaling and YAP1/β-catenin: Similar cell cycle control in tumor initiation
Keywords: YAP1; Yes; MAPK; mitogen-activated protein kinase; ERK; extracellular signal-regulated kinase; eIF4E; eukaryotic translation initiation factor 4E; PI3K; phosphatidylinositide-3-kinase; WNT; Wingless-type mouse mammary tumor virus integration site family m
New acyclic bis phenylpropanoid and neolignans, from Myristica fragrans Houtt., exhibiting PARP-1 and NF-κB inhibitory effects
Keywords: Myristica fragrans; Mace; Neolignans; Acyclic bisphenyl propanoids; PARP-1; NF-κB; K-Ras;
Associations of positive epidermal growth factor receptor expression and K-RAS gene mutations with various clinicopathological parameters and survival of colorectal carcinoma patients
Keywords: colorectal cancer; epidermal growth factor receptor; K-RAS; mutation
Caractérisation de populations tumorales dans les cancers bronchiques non à petites cellules en TEP au FDG en fonction de critères anatomopathologiques et génétiques
Keywords: TEP FDG; Cancers pulmonaires; Anatomopathologie; K-ras; Epidermal growth factor receptor (EGFR)FDG-PET; Lung cancer; Pathology; K-ras; Epidermal growth factor receptor (EGFR)
The mucin MUC4 is a transcriptional and post-transcriptional target of K-ras oncogene in pancreatic cancer. Implication of MAPK/AP-1, NF-κB and RalB signaling pathways
Keywords: MUC4; K-ras; RalB; Pancreatic cancer; Transcription; APâ1;
Hsa-miR-1 suppresses breast cancer development by down-regulating K-ras and long non-coding RNA MALAT1
Keywords: miR-1; K-RAS; MALAT1;
Inhibition of fatty acid synthase induces pro-survival Akt and ERK signaling in K-Ras-driven cancer cells
Keywords: FAS, fatty acid synthase; IGF-1R, insulin-like growth factor-1 receptor; mTORC2, mammalian/mechanistic target of rapamycin complex 2; PI3K, phosphatidylinositol 3-kinaseFatty acid synthase; K-Ras; Akt; ERK
GATA2 is Epigenetically Repressed in Human and Mouse Lung Tumors and Is Not Requisite for Survival of KRAS Mutant Lung Cancer
Keywords: GATA2; Epigenetics; K-RAS; Mutation; Carcinogenesis;
Differential response to 1α,25-dihydroxyvitamin D3 (1α,25(OH)2D3) in non-small cell lung cancer cells with distinct oncogene mutations
Keywords: Non-small cell lung cancer; Vitamin D receptor; 1,25-Dihydroxyvitamin D3; Epidermal growth factor receptor; K-ras; CSS; charcoal-stripped serum; DMSO; dimethylsulfoxide; EGFR; epidermal growth factor receptor; FBS; fetal bovine serum; 1,25(OH)2D3; 1,25-di
Assessment of K-Ras mutant frequency and micronucleus incidence in the mouse duodenum following 90-days of exposure to Cr(VI) in drinking water
Keywords: Hexavalent chromium; K-Ras; Mutation; Micronucleus; Cancer risk assessment;
Non-Epstein–Barr virus associated lymphoepithelioma-like carcinoma of the esophagogastric junction with microsatellite instability, K-ras wild type
Keywords: Lymphoepithelioma-like carcinoma; Esophagogastric junction; Microsatellite instability; K-ras
Involvement of oncogenic K-ras on cell migration stimulated by lysophosphatidic acid receptor-2 in pancreatic cancer cells
Keywords: LPA; LPA receptor; K-ras; Cell migration; Pancreatic cancer
CSE1L modulates Ras-induced cancer cell invasion: correlation of K-Ras mutation and CSE1L expression in colorectal cancer progression
Keywords: Colorectal cancer; CSE1L; K-Ras; Lymph node; Metastasis
Inflammation, Autophagy, and Obesity: Common Features in the Pathogenesis of Pancreatitis and Pancreatic Cancer
Keywords: Pancreatic Acinar Cell; Cytokines; Neutrophil; Pancreatic Ductal Adenocarcinoma; K-Ras; AMP; adenosine monophosphate; AP; acute pancreatitis; ATG; autophagy related; Cat; cathepsin; CP; chronic pancreatitis; DAMP; damage/danger-associated molecular patter
A comparative analysis of K-ras mutation and carcinoembryonic antigen in pancreatic cyst fluid
Keywords: K-ras; Carcinoembryonic antigen (CEA); Cystic pancreatic tumors; Molecular carcinogenesis; Fluid analysis;
Characteristics of lung cancer in women: Importance of hormonal and growth factors
Keywords: Lung cancer; EGFR; K-Ras; Estrogen receptor; Prognosis;
Association of folate intake, dietary habits, smoking and COX-2 promotor −765G > C polymorphism with K-ras mutation in patients with colorectal cancer
Keywords: Folate; Colorectal cancer; K-ras; Cyclooxygenase 2
Clonality status of multifocal lung adenocarcinomas based on the mutation patterns of EGFR and K-ras
Keywords: Adenocarcinoma; Multiple primary lung cancer; Pulmonary metastasis; Epidermal growth factor receptor; K-ras; Clonality
Antroquinonol, a natural ubiquinone derivative, induces a cross talk between apoptosis, autophagy and senescence in human pancreatic carcinoma cells
Keywords: Akt; mTOR; K-ras; Pancreatic cancer; Bcl-xL
Novel approach to abuse the hyperactive K-Ras pathway for adenoviral gene therapy of colorectal cancer
Keywords: Colorectal cancer (CRC); K-Ras; PUMA; Adenovirus; Gene therapy
Increased Ras GTPase activity is regulated by miRNAs that can be attenuated by CDF treatment in pancreatic cancer cells
Keywords: Ras GTPase activity; K-Ras; miRNAs; CDF; Xenograft mouse model
K-Ras mutation-mediated IGF-1-induced feedback ERK activation contributes to the rapalog resistance in pancreatic ductal adenocarcinomas
Keywords: K-Ras; mTORC1; Rapalog; ERK; Pancreatic cancer
Morphological and molecular heterogeneity in colorectal neoplasms with K-RAS mutation. A report of two cases
Keywords: K-RAS; Heterogeneity; Colorectal cancer; Signet ring cell carcinoma
Summary of Presentations from the 46th Annual Meeting of the American Society of Clinical Oncology (2010) Focus on Tumor Biology and Biomarkers Related to Lung Cancer
Keywords: Lung cancer; NSCLC; Tumor biology; EML4-ALK; EGFR; Gene expression; K-ras; Mesothelioma
EUS-FNA Mutational Analysis in Differentiating Autoimmune Pancreatitis and Pancreatic Cancer
Keywords: Pancreatic cancer; Autoimmune pancreatitis; Endoscopic ultrasound; K-ras;
RASSF1A suppresses the activated K-Ras-induced oxidative DNA damage
Keywords: K-Ras; RASSF1A; ROS; DNA damage